Predictors of knowledge of and access to biomedical prevention among MSM and transgender men in Latin America: Results from the Latin American internet survey

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorAVELINO-SILVA, Vivian Iida
dc.contributor.authorVASCONCELOS, Ricardo
dc.contributor.authorCERQUEIRA, Natalia B.
dc.contributor.authorMARCUS, Ulrich
dc.contributor.authorSCHMIDT, Axel Jeremias
dc.contributor.authorVERAS, Maria Amelia
dc.date.accessioned2022-08-12T17:07:43Z
dc.date.available2022-08-12T17:07:43Z
dc.date.issued2022
dc.description.abstractIntroduction HIV is still a central public health issue in Latin America, disproportionally affecting key populations. Knowledge and access to biomedical prevention strategies, including treatment as prevention (TASP) or undetectable = untransmissible (U=U), pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP), are the first steps to increasing uptake. We used data from the Latin American MSM Internet Survey (LAMIS) to describe knowledge and access to biomedical HIV prevention strategies among gay, bisexual, transgender and other men who have sex with men (MSM) living in 18 Latin American countries. Methods We compared LAMIS data across countries and according to age categories using frequencies and percentages. We also used multivariable models to explore whether age, gender identity, sexual identity, steady partnership, HIV status and education were independently associated with outcomes. Results In all, 55 924 participants were included. Most were cisgender (99%) and identified as gay/homosexual (77%) or bisexual (17%). Schooling levels were very high, with 89% reporting highest attained education as tertiary level, university or post-graduation. In total, 16% had been previously diagnosed with HIV; of those, rates of undetectable viral load varied from 60% in Venezuela to 83% in Brazil. Overall, 54%, 54% and 52% of participants already knew about PEP, PrEP and U=U, respectively. Participants from Brazil and those aged between 26 and 55 years, living with diagnosed HIV and having a gay/homosexual identity had greater levels of awareness about biomedical prevention strategies. Conclusions Our study highlights gaps in HIV prevention campaigns directed to MSM in Latin America resulting in low uptake of biomedical prevention methods.eng
dc.description.indexMEDLINEeng
dc.description.sponsorshipEU Health Programme 2014-2020 for Europe
dc.description.sponsorshipCEEISCAT, CIISSS, Instituto de Saude Publica da Universidade do Porto, Maastricht University
dc.identifier.citationHIV MEDICINE, v.23, n.7, p.764-773, 2022
dc.identifier.doi10.1111/hiv.13238
dc.identifier.eissn1468-1293
dc.identifier.issn1464-2662
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/48424
dc.language.isoeng
dc.publisherWILEYeng
dc.relation.ispartofHiv Medicine
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright WILEYeng
dc.subjecthighly active antiretroviral therapyeng
dc.subjectpost-exposure prophylaxiseng
dc.subjectpre-exposure prophylaxiseng
dc.subjectsexual and gender minoritieseng
dc.subjecttransgender personseng
dc.subjectundetectable = untransmissibleeng
dc.subject.otherhiv prevalenceeng
dc.subject.othersexeng
dc.subject.otherepidemiceng
dc.subject.otherwomeneng
dc.subject.wosInfectious Diseaseseng
dc.titlePredictors of knowledge of and access to biomedical prevention among MSM and transgender men in Latin America: Results from the Latin American internet surveyeng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.affiliation.countryInglaterra
hcfmusp.affiliation.countryAlemanha
hcfmusp.affiliation.countryisode
hcfmusp.affiliation.countryisogb
hcfmusp.author.externalMARCUS, Ulrich:Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany
hcfmusp.author.externalSCHMIDT, Axel Jeremias:London Sch Hyg & Trop Med, Dept Publ Hlth Environm & Soc, Sigma Res, London, England
hcfmusp.author.externalVERAS, Maria Amelia:Fac Ciencias Med Santa Casa Sao Paulo, Sao Paulo, Brazil
hcfmusp.citation.scopus1
hcfmusp.contributor.author-fmusphcVIVIAN HELENA IIDA AVELINO DA SILVA
hcfmusp.contributor.author-fmusphcRICARDO DE PAULA VASCONCELOS
hcfmusp.contributor.author-fmusphcNATALIA BARROS CERQUEIRA
hcfmusp.description.beginpage764
hcfmusp.description.endpage773
hcfmusp.description.issue7
hcfmusp.description.volume23
hcfmusp.origemWOS
hcfmusp.origem.pubmed35068053
hcfmusp.origem.scopus2-s2.0-85123481600
hcfmusp.origem.wosWOS:000745718000001
hcfmusp.publisher.cityHOBOKENeng
hcfmusp.publisher.countryUSAeng
hcfmusp.relation.reference[Anonymous], 2020, UNAIDS DATAeng
hcfmusp.relation.referenceBastos FI, 2008, INT J EPIDEMIOL, V37, P729, DOI 10.1093/ije/dyn127eng
hcfmusp.relation.referenceBautista-Arredondo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072616eng
hcfmusp.relation.referenceCaceres CF, 2003, INT J EPIDEMIOL, V32, P740, DOI 10.1093/ije/dyg214eng
hcfmusp.relation.referenceCoelho LE, 2021, AIDS BEHAV, V25, P3223, DOI 10.1007/s10461-021-03180-5eng
hcfmusp.relation.referenceDe Boni R, 2014, CURR OPIN HIV AIDS, V9, P192, DOI 10.1097/COH.0000000000000031eng
hcfmusp.relation.referenceFrenk J, 2018, ARCH MED RES, V49, P79, DOI 10.1016/j.arcmed.2018.06.002eng
hcfmusp.relation.referenceGarcia PJ, 2014, CURR HIV-AIDS REP, V11, P146, DOI 10.1007/s11904-014-0204-1eng
hcfmusp.relation.referenceKerr L, 2018, MEDICINE, V97, pS9, DOI [10.1097/MD.0000000000010573, 10.1097/md.0000000000010573]eng
hcfmusp.relation.referenceKerr LRFS, 2013, AIDS, V27, P427, DOI 10.1097/QAD.0b013e32835ad504eng
hcfmusp.relation.referenceLevi J, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2015-000010eng
hcfmusp.relation.referenceLuz PM, 2019, CURR OPIN HIV AIDS, V14, P366, DOI 10.1097/COH.0000000000000564eng
hcfmusp.relation.referenceMatacotta JJ, 2020, J PATIENT-CENTER RES, V7, P265, DOI 10.17294/2330-0698.1737eng
hcfmusp.relation.referenceSousa LRM, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-020-10135-3eng
hcfmusp.relation.referenceMiller WM, 2013, SALUD PUBLICA MEXICO, V55, pS65eng
hcfmusp.relation.referenceNgure K, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25466eng
hcfmusp.relation.referenceNunes NN., 2020, 12 C PAUL INFeng
hcfmusp.relation.referenceSiegel K, 2019, AIDS BEHAV, V23, P1974, DOI 10.1007/s10461-019-02405-yeng
hcfmusp.relation.referenceThe EMIS Network,, 2019, EMIS 2017 EUR MEN WHeng
hcfmusp.relation.referenceTorres TS, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25630eng
hcfmusp.relation.referenceTorres TS, 2019, AIDS CARE, V31, P1193, DOI 10.1080/09540121.2019.1619665eng
hcfmusp.relation.referenceTorres TS, 2019, JMIR PUBLIC HLTH SUR, V5, P177, DOI 10.2196/13771eng
hcfmusp.relation.referenceVergara-Ortega DN, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06582-xeng
hcfmusp.relation.referenceWeatherburn P, 2020, SEX RES SOC POLICY, V17, P543, DOI 10.1007/s13178-019-00413-0eng
hcfmusp.relation.referenceWeatherburn P, 2013, SEX RES SOC POLICY, V10, P243, DOI 10.1007/s13178-013-0119-4eng
hcfmusp.relation.referenceWinter S, 2016, LANCET, V388, P390, DOI 10.1016/S0140-6736(16)00683-8eng
hcfmusp.relation.referenceYi S, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21580eng
hcfmusp.relation.referenceZea MC, 2015, AM J PUBLIC HEALTH, V105, P1588, DOI 10.2105/AJPH.2014.302307eng
hcfmusp.relation.referenceZeeman L, 2019, EUR J PUBLIC HEALTH, V29, P974, DOI 10.1093/eurpub/cky226eng
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublication86c321c7-5cde-4865-b233-ae342a5e5dee
relation.isAuthorOfPublication269518fc-f3c4-44db-852a-43298ec8fe92
relation.isAuthorOfPublication45dc6aed-5f3a-4204-940a-404921741dd4
relation.isAuthorOfPublication.latestForDiscovery86c321c7-5cde-4865-b233-ae342a5e5dee
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_AVELINO-SILVA_Predictors_of_knowledge_of_and_access_to_biomedical_2022.PDF
Tamanho:
1.03 MB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/49
Artigos e Materiais de Revistas Científicas - ODS/03
Artigos e Materiais de Revistas Científicas - ODS/05